Healing Thresholds - Connecting Community and Science to Heal Autism

atypical antipsychotic

Olanzapine in the Treatment of Behavioral Problems Associated with Autism: An Open-Label Trial in Kuwait Fido, A.; AlSaad, S. , Medical Principles and Practices, Volume 17, Issue 5, p.415-418, (2008) Layperson Summary

Metabolic Effects of Atypical Antipsychotics Tahir, R. , US Pharm, Volume 32, Issue 11, p.HS3-HS14, (2007) Layperson Summary

Psychopharmacological Treatment of Non-Comorbid and Comorbid Pervasive Developmental Disorder and Pediatric Bipolar Disorder Hamrin, V.; McDonnell, M.; Moffett, J.; Durso, S. , Minerva Pediatrics, Volume 60, Issue 1, p.87-101, (2008) Layperson Summary

Observed Clinical and Health Services Outcomes in Pediatric Inpatients Treated with Atypical Antipsychotics: 1999-2003 FLanders, S.; Findling, R.; Youngstrom, E.; Pandina, G.; Rupnow, M.; Jensik, S.; Carlson, G. , Journal of Child and Adolescent Psychopharmacology, Volume 17, Issue 3, p.312-327, (2007) Layperson Summary

A Double-Blind Placebo-Controlled Pilot Study of Olanzapine in Childhood/Adolescent Pervasive Developmental Disorder Hollander, E.; Wasserman, S.; Swanson, E.; Chaplin, W.; Schapiro, M.; Zagursky, K.; Novotny, S. , Journal of Child and Adolescent Pharmacology, Volume 16, Issue 5, p.541-548, (2006) Layperson Summary